Difference between succinate and tartrate
Pro Research Analysisby 
Searched over 200M research papers
Differences Between Succinate and Tartrate
Introduction to Succinate and Tartrate
Succinate and tartrate are two different types of salts that are often used in pharmaceuticals and other chemical applications. Despite their similarities, they exhibit distinct behaviors and properties that can influence their effectiveness and application in various fields.
Structural and Thermal Properties
Solid-State Structure and Behavior
The solid-state structures of metoprolol tartrate (MT-o) and metoprolol succinate (MS-m) have been extensively studied. Both salts show close similarity at the molecular level in their crystal lattices. However, calorimetric data indicate that MS-m has a slightly greater cohesive energy compared to MT-o. Additionally, MS-m undergoes reversible anisotropic lattice expansion and contraction upon temperature changes, and it quickly recrystallizes to its original crystal phase after melting. In contrast, MT-o expands and contracts isotropically and forms an amorphous solid upon cooling from the melt, which takes six days to revert to its original crystalline form1.
Coordination Polymers and Layered Double Hydroxides
L-tartrate ions can form robust, enantiopure open-framework coordination polymers under hydrothermal conditions, while the addition of succinate results in the formation of related structures with larger channels. This difference in channel size can be attributed to the distinct molecular structures of tartrate and succinate4. Furthermore, the intercalation of tartrate and succinate anions in Zn(3)Al and Zn(2)Cr layered double hydroxides (LDHs) shows that both anions lead to expanded LDH with similar basal spacing. However, tartrate-containing LDHs exhibit unique reactivity and structural behavior compared to succinate-containing LDHs6 7.
Pharmacokinetics and Clinical Efficacy
Pharmacokinetics of Solifenacin Salts
A study comparing the pharmacokinetic properties of solifenacin tartrate and solifenacin succinate found that both formulations have similar pharmacokinetic profiles and meet the criteria for bioequivalence. The mean values of AUClast and Cmax for both formulations were comparable, and no significant differences were observed in safety assessments2.
Clinical Efficacy in Vasospastic Angina
In patients with vasospastic angina, metoprolol succinate demonstrated a significant advantage over metoprolol tartrate in reducing the incidence of clinically significant angina attacks. However, there were no significant differences between the two salts in terms of cardiovascular mortality, development of acute myocardial infarction (AMI), or stroke3.
Environmental and Toxicological Aspects
Environmental Toxicology
Succinate tartrates, a mixture of organic builders used in commercial cleaning products, have been evaluated for their environmental safety. Toxicological studies indicate that succinate tartrates have low toxicity to various species of freshwater and marine organisms, with median effect concentrations ranging from 110 to over 1000 mg/L. The studies also show an inverse relationship between water hardness and toxicity8.
Conclusion
Succinate and tartrate salts, while similar in some respects, exhibit distinct differences in their structural, thermal, pharmacokinetic, and clinical properties. These differences can significantly impact their application in pharmaceuticals and other fields. Understanding these distinctions is crucial for optimizing their use in various contexts.
Sources and full results
Most relevant research papers on this topic